A Multicentre, Double-Blind, Randomized, Placebo Controlled, Parallel group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (DESTINATION)

  • Gillman, Andrew (Primary Chief Investigator (PCI))
  • Hazard, Anita (Project Manager)

Project: Research

Project Details

Effective start/end date2/12/191/05/22


  • Respiratory medicine
  • Asthma
  • Clinical trial